Valeant Faces New Fraud Lawsuit Filed By Former Investor

Published: Aug 19, 2016

T. Rowe Price is suing Valeant Pharmaceuticals, alleging fraud, according to The Wall Street Journal.

The mutual fund is an investor in the company.

In the suit, it accuses Valeant of running a "fraudulent scheme" through its now defunct pharmacy, Philidor.

Back to news